1. A real-world comparative analysis of carfilzomib and other systemic multiple myeloma chemotherapies in a US community oncology setting. (January 2019) Authors: Rifkin, Robert M.; Medhekar, Rohan; Amirian, E. Susan; Aguilar, Kathleen M.; Wilson, Thomas; Boyd, Marley; Mezzi, Khalid; Panjabi, Sumeet Journal: Therapeutic advances in hematology Issue: Volume 10(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Burden of disease progression in patients with multiple myeloma in the US. Issue 1 (2nd January 2020) Authors: Hagiwara, May; Panjabi, Sumeet; Delea, Tom; Yucel, Emre; Fonseca, Rafael Journal: Leukemia & lymphoma Issue: Volume 61:Issue 1(2020) Page Start: 47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical and economic outcomes associated with amlodipine/renin–angiotensin system blocker combinations. (February 2013) Authors: Ferrario, Carlos M.; Panjabi, Sumeet; Buzinec, Paul; Swindle, Jason P. Journal: Therapeutic advances in cardiovascular disease Issue: Volume 7:Number 1(2013) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cost of peripheral neuropathy in patients receiving treatment for multiple myeloma: a US administrative claims analysis. (March 2019) Authors: Song, Xue; Wilson, Kathleen L.; Kagan, Jerry; Panjabi, Sumeet Journal: Therapeutic advances in hematology Issue: Volume 10(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cost-effectiveness of adding carfilzomib to lenalidomide and dexamethasone in relapsed multiple myeloma from a US perspective. (1st November 2016) Authors: Jakubowiak, Andrzej J.; Campioni, Marco; Benedict, Ágnes; Houisse, Ivan; Tichy, Eszter; Giannopoulou, Andromachi; Aggarwal, Sanjay K.; Barber, Beth L.; Panjabi, Sumeet Journal: Journal of medical economics Issue: Volume 19:Number 11(2016) Page Start: 1061 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cost-effectiveness of carfilzomib plus dexamethasone compared with bortezomib plus dexamethasone for patients with relapsed or refractory multiple myeloma in the United States. Issue 12 (2nd December 2017) Authors: Jakubowiak, Andrzej J.; Houisse, Ivan; Májer, István; Benedict, Ágnes; Campioni, Marco; Panjabi, Sumeet; Ailawadhi, Sikander Journal: Expert review of hematology Issue: Volume 10:Issue 12(2017) Page Start: 1107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Cost-effectiveness of once weekly carfilzomib 70 mg/m2 plus dexamethasone in patients with relapsed and refractory multiple myeloma in the United States. Issue 6 (2nd June 2020) Authors: Kumar, Shaji K.; Majer, Istvan; Panjabi, Sumeet; Medhekar, Rohan; Campioni, Marco; Dimopoulos, Meletios A. Journal: Expert review of hematology Issue: Volume 13:Issue 6(2020) Page Start: 687 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Cost-effectiveness of once weekly carfilzomib 70 mg/m2 plus dexamethasone in patients with relapsed and refractory multiple myeloma in the United States. Issue 6 (2nd June 2020) Authors: Kumar, Shaji K.; Majer, Istvan; Panjabi, Sumeet; Medhekar, Rohan; Campioni, Marco; Dimopoulos, Meletios A. Journal: Expert review of hematology Issue: Volume 13:Issue 6(2020) Page Start: 687 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Development and evaluation of a predictive algorithm for unsatisfactory response among patients with pulmonary arterial hypertension using health insurance claims data. (3rd June 2022) Authors: Gauthier-Loiselle, Marjolaine; Tsang, Yuen; Lefebvre, Patrick; Agron, Peter; Royer, Jimmy; Bell Lynum, Karimah S.; Bennett, Lucas; Panjabi, Sumeet Journal: Current medical research and opinion Issue: Volume 38:Number 6(2022) Page Start: 1019 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Development and validation of a claims-based model to identify patients at risk of chronic thromboembolic pulmonary hypertension following acute pulmonary embolism. (2nd September 2021) Authors: Kanwar, Manreet K.; Cole, Michele; Gauthier-Loiselle, Marjolaine; Manceur, Ameur M.; Tsang, Yuen; Lefebvre, Patrick; Panjabi, Sumeet; Benza, Raymond L. Journal: Current medical research and opinion Issue: Volume 37:Number 9(2021) Page Start: 1483 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗